Marine Excipient refers to ingredients derived from marine organisms used in pharmaceutical formulations.

The global Marine Excipient market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime, Inc. (LPI) 's newest research report, the “Marine Excipient Industry Forecast” looks at past sales and reviews total world Marine Excipient sales in 2023, providing a comprehensive analysis by region and market sector of projected Marine Excipient sales for 2024 through 2030.

This Insight Report provides a comprehensive analysis of the global Marine Excipient landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

Segmentation by type:

• Marine Food Accessories
• Marine Pharmaceutical Excipients
• Marine Cosmetics Accessories

Segmentation by application:

• Food Industry
• Pharmaceutical Industry
• Cosmetics Industry

This report also splits the market by region:

• Americas
• APAC
• Europe
• Middle East & Africa

Companies covered:

• Blue Biotech
• Earthrise
• Roquette Kloetze
• Rizhao Jiejing Ocean Biotechnology Development Co., LTD
• AlgaNovo International Co., Ltd
• Yigeda Bio-Technology Co., Ltd
• EID Parry
• BASF (Cognis Australia, Betatene/BASF (DE))
• Natural Beta Technologies
• Cyanotech
• Mera Pharma
• BioReal
• US Nutra
• AlgaTech
• SandaKing
• DIC Lifetec
• Marcel Carrageenan
• Zamboanga Carrageenan
• Multicipta Infodevindo
• PT Sumber Alam Lestari
• Meck Pharmaceuticals & Chemicals Pvt. Ltd.

Key Questions Addressed in this Report

• What is the 10-year outlook for the global Marine Excipient market?
• What factors are driving Marine Excipient market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Marine Excipient market opportunities vary by end market size?
• How does Marine Excipient break out type, application?